[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354243-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354243-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","recent-advances-in-dissolving-microneedles-for-breast-cancer-immunotherapy-local-delivery-and-tumor-microenvironment-remodeling","Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling","","Breast cancer shows limited immunogenicity, and while immune checkpoint inhibitors can benefit some triple-negative cases, overall response rates are constrained by therapeutic heterogeneity and systemic immune-related toxicities. The immunosuppressive tumor immune microenvironment, with impaired antigen presentation, reduced effector T-cell infiltration, and enrichment of suppressive immune cells, blocks durable immunotherapy. This review summarizes dissolving microneedles as a minimally invasive transdermal platform that enables localized immunodelivery to antigen-presenting cell–rich epidermis and superficial dermis, promoting peripheral immune priming while reducing systemic exposure. It details microstructural design, immunodelivery properties, mechanisms for remodeling the TIME, and prospects for combination strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/recent-advances-in-dissolving-microneedles-for-breast-cancer-immunotherapy-local-delivery-and-tumor-microenvironment-remodeling/354243/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/recent-advances-in-dissolving-microneedles-for-breast-cancer-immunotherapy-local-delivery-and-tumor-microenvironment-remodeling/354243.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is breast cancer immunotherapy often challenging despite immune checkpoint inhibitors?","Question",{"text":63,"@type":64},"Breast cancer is generally low in immunogenicity, with limited antigen presentation and an immunosuppressive tumor immune microenvironment that restricts effector T-cell infiltration, reducing durable responses to ICIs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do dissolving microneedles help deliver immunotherapy more effectively?",{"text":68,"@type":64},"Dissolving microneedles bypass the stratum corneum barrier and deliver antigens and immunomodulatory molecules into the epidermis and superficial dermis enriched with antigen-presenting cells, enabling efficient peripheral immune priming while limiting systemic exposure.",{"name":70,"@type":61,"acceptedAnswer":71},"What aspects of dissolving microneedles does the review cover?",{"text":72,"@type":64},"The review covers material composition and microstructural design, transdermal immunodelivery characteristics, mechanisms of peripheral immune activation, and how these systems may remodel the tumor immune microenvironment, including potential combination approaches.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354243,1790192994,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Review  \nPUBLISHED 15 May 2026  \nDOI 10.3389/fimmu.2026.1831221  \nOPEN ACCESS  \nEDITED BY  \nAsgar Ali,  \nJamia Millia Islamia, India  \nREVIEWED BY  \nDharmendra Kumar Yadav,  \nGachon University, Republic of Korea Desh Deepak Singh,  \nAmity University Jaipur, India  \n*CORRESPONDENCE  \nHui Pang  \n [panghui@hrbmu.edu.cn](panghui@hrbmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 15 March 2026  \nREVISED 21 April 2026  \nACCEPTED 04 May 2026  \nPUBLISHED 15 May 2026  \nCITATION  \nChen Y, Song L, Zhu Y, Zhang Z, Lu Y, Wang X and Pang H (2026) Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling.  \nFront. Immunol. 17:1831221 .  \ndoi: 10.3389/fimmu.2026.1831221  \nCOPYRIGHT  \n© 2026 Chen, Song, Zhu, Zhang, Lu, Wang and Pang. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRecent advances in dissolving microneedles for breast cancer immunotherapy:  \nlocal delivery and tumor microenvironment remodeling  \nYingcui Chen 1†, Li Song 2†, Yingze Zhu 1, Zhuoqi Zhang 1, Yige Lu 1, Xinyue Wang 1 and Hui Pang 1*  \n1The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China, 2 Department of Oncology, Jiamusi Tumor Hospital, Jiamusi, Heilongjiang, China  \nBreast cancer is generally characterized by limited immunogenicity. Although immune checkpoint inhibitors (ICIs) provide survival beneﬁts in a subset of patients with triple-negative breast cancer (TNBC), overall response rates remain limited and are accompanied by pronounced therapeutic heterogeneity and systemic immune-related adverse events. The immunosuppressive tumor immune microenvironment (TIME), characterized by restricted antigen presentation, limited effector T-cell inﬁltration, and enrichment of immunosuppressive cell populations, represents a key barrier to durable immunotherapy beneﬁt. Dissolving microneedles (DMNs) represent a minimally invasive transdermal delivery system that bypasses the stratum corneum barrier. They enable the delivery of antigens and immunomodulatory molecules into the epidermis and superﬁcial dermis enriched in antigen-presenting cells (APCs), thereby facilitating efﬁcient peripheral immune priming while reducing systemic exposure. This review summarizes the material composition and microstructural design of DMNs, their transdermal immunodelivery characteristics, and recent advancesin breast cancer immunotherapy. It further highlights the mechanisms by which DMNs mediate peripheral immune activation and remodel the TIME, as well as their potential in combination with other immunotherapeutic strategies. Overall, DMNs represent a promising strategy that may improve the efﬁcacy and safety of breast cancer immunotherapy by enabling localized delivery, efﬁcient peripheral activation, and coordinated microenvironment remodeling.  \nKEYWORDS  \nbreast cancer, dissolving microneedles, immunotherapy, transdermal immunodelivery, tumor immune microenvironment  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nChen et al. 10.3389/fimmu.2026.1831221  \nGRAPHICAL ABSTRACT  \n1 Introduction  \nBreast cancer is one of the most commonly diagnosed malignancies among women worldwide and remains a leading cause of cancer-related mortality. According to global cancer statistics, approximately 2.3 million new cases of breast cancer were diagnosed worldwide in 2022, accounting for more than 11% of all newly diagnosed cancers, with an estimated 660,000 associated deaths. Notably, the incidence of breast cancer has conti","cbCaid3kcCQ4T1Ut","https://ap.wps.com/l/cbCaid3kcCQ4T1Ut","pdf",2796959,"English","# Introduction\n# Dissolving microneedles for transdermal immunodelivery\n## Material composition and microstructural design\n## Peripheral immune activation mechanisms\n# Remodeling the tumor immune microenvironment\n# Combination with other immunotherapeutic strategies","[{\"question\":\"Why is breast cancer immunotherapy often challenging despite immune checkpoint inhibitors?\",\"answer\":\"Breast cancer is generally low in immunogenicity, with limited antigen presentation and an immunosuppressive tumor immune microenvironment that restricts effector T-cell infiltration, reducing durable responses to ICIs.\"},{\"question\":\"How do dissolving microneedles help deliver immunotherapy more effectively?\",\"answer\":\"Dissolving microneedles bypass the stratum corneum barrier and deliver antigens and immunomodulatory molecules into the epidermis and superficial dermis enriched with antigen-presenting cells, enabling efficient peripheral immune priming while limiting systemic exposure.\"},{\"question\":\"What aspects of dissolving microneedles does the review cover?\",\"answer\":\"The review covers material composition and microstructural design, transdermal immunodelivery characteristics, mechanisms of peripheral immune activation, and how these systems may remodel the tumor immune microenvironment, including potential combination approaches.\"}]","Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling | PDF",1790109714,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e364bec718c03023bc32519f5e1bc02.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e85ea6f8e0a33807030249caf84ead8a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e70b192f41adf35733fa9583cad511bb.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41337834de4241e8aca6fe40862aef1a.webp",980,1385]